These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6144046)

  • 1. Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites.
    Martres MP; Sokoloff P; Delandre M; Schwartz JC; Protais P; Costentin J
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):102-15. PubMed ID: 6144046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-Dopamine binding sites differ in rat striatum and pituitary.
    Sokoloff P; Martres MP; Delandre M; Redouane K; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):221-7. PubMed ID: 6493362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites.
    Sokoloff P; Redouane K; Brann M; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):236-43. PubMed ID: 4022135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.
    Vasse M; Protais P; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):108-16. PubMed ID: 4040215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
    Lin C; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.
    Protais P; Bonnet JJ; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):93-101. PubMed ID: 6425703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?
    Ljungberg T
    J Neural Transm; 1989; 76(2):79-90. PubMed ID: 2565360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration.
    Protais P; Hermier C; Costentin J
    Neuropharmacology; 1985 Sep; 24(9):861-7. PubMed ID: 2865694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
    Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.
    Fleminger S; van de Waterbeemd H; Rupniak NM; Reavill C; Testa B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1983 Jun; 35(6):363-8. PubMed ID: 6135774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.